1. Home
  2. YDKG vs MBIO Comparison

YDKG vs MBIO Comparison

Compare YDKG & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yueda Digital Holding Class A Ordinary Share

YDKG

Yueda Digital Holding Class A Ordinary Share

N/A

Current Price

$1.04

Market Cap

4.9M

ML Signal

N/A

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.07

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDKG
MBIO
Founded
2005
2015
Country
China
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9M
4.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YDKG
MBIO
Price
$1.04
$1.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
140.0K
75.1K
Earning Date
03-06-2026
11-07-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$13,107,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2175.52
N/A
52 Week Low
$0.81
$0.89
52 Week High
$669.00
$7.00

Technical Indicators

Market Signals
Indicator
YDKG
MBIO
Relative Strength Index (RSI) N/A 43.96
Support Level N/A $1.07
Resistance Level N/A $1.20
Average True Range (ATR) 0.00 0.06
MACD 0.00 0.01
Stochastic Oscillator 0.00 50.00

Price Performance

Historical Comparison
YDKG
MBIO

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a digital-economy company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: